Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis

[1]  W. Seeger,et al.  The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis , 2018, Respiratory Research.

[2]  M. Kreuter,et al.  Metformin Does Not Affect Clinically Relevant Outcomes in Patients with Idiopathic Pulmonary Fibrosis , 2018, Respiration.

[3]  D. Bouros,et al.  Metformin in Idiopathic Pulmonary Fibrosis “Seeking the Holy-Grail through Drug-Repositioning” , 2018, Respiration.

[4]  E. Abraham,et al.  Metformin reverses established lung fibrosis in a bleomycin model , 2018, Nature Medicine.

[5]  Charles E. Leonard,et al.  Comparative risk of serious hypoglycemia with oral antidiabetic monotherapy: A retrospective cohort study , 2018, Pharmacoepidemiology and drug safety.

[6]  L. Castilla-Guerra,et al.  Antidiabetic drugs and stroke risk. Current evidence. , 2017, European journal of internal medicine.

[7]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[8]  F. Yan,et al.  Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics , 2017, BMC Pulmonary Medicine.

[9]  W. Seeger,et al.  Mesenchymal Stem Cells in Fibrotic Disease. , 2017, Cell stem cell.

[10]  S. Keshavjee,et al.  Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study , 2017, BMJ Open Respiratory Research.

[11]  G. Hansmann,et al.  PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism. , 2017, Cell metabolism.

[12]  J. Yang,et al.  Metformin inhibits SUV39H1-mediated migration of prostate cancer cells , 2017, Oncogenesis.

[13]  K. Xie,et al.  Progress in the application and mechanism of metformin in treating non-small cell lung cancer , 2017, Oncology letters.

[14]  W. Seeger,et al.  Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis. , 2017, Cell stem cell.

[15]  E. Åhrman,et al.  Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis. , 2017, The international journal of biochemistry & cell biology.

[16]  B. Viollet,et al.  Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms , 2016, Molecular and Cellular Endocrinology.

[17]  K. Kuwano,et al.  Metformin attenuates lung fibrosis development via NOX4 suppression , 2016, Respiratory Research.

[18]  M. Dobelbower,et al.  Correction: Kinomic Profiling of Electromagnetic Navigational Bronchoscopy Specimens: A New Approach for Personalized Medicine , 2016, PloS one.

[19]  P. Chambon,et al.  Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis. , 2016, The Journal of clinical investigation.

[20]  A. Gaggar,et al.  Matrix Remodeling in Pulmonary Fibrosis and Emphysema. , 2016, American journal of respiratory cell and molecular biology.

[21]  L. Richeldi,et al.  Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history , 2016, Respirology.

[22]  P. Chambon,et al.  Transcription factor TBX4 regulates myofibroblast accumulation and lung fibrosis. , 2016, The Journal of clinical investigation.

[23]  G. Naik,et al.  High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes , 2015, PloS one.

[24]  M. Lindner,et al.  Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures , 2015, European Respiratory Journal.

[25]  B. Ebert,et al.  Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. , 2015, Cell stem cell.

[26]  M. Dobelbower,et al.  Kinomic Profiling of Electromagnetic Navigational Bronchoscopy Specimens: A New Approach for Personalized Medicine , 2014, PloS one.

[27]  C. Semenkovich,et al.  Peroxisomes: a nexus for lipid metabolism and cellular signaling. , 2014, Cell metabolism.

[28]  G. Nöldge-Schomburg,et al.  Rosiglitazone Dampens Pulmonary Inflammation in a Porcine Model of Acute Lung Injury , 2014, Inflammation.

[29]  E. White,et al.  Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis. , 2013, American journal of respiratory cell and molecular biology.

[30]  Hongli Sun,et al.  Osteoblast‐Targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling , 2013, Stem cells.

[31]  K. Pouwels,et al.  The rosiglitazone decision process at FDA and EMA. What should we learn? , 2013, The International journal of risk & safety in medicine.

[32]  Cynthia Davidson,et al.  MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. , 2012, American journal of respiratory cell and molecular biology.

[33]  N. Ambalavanan,et al.  Thy-1 signals through PPARγ to promote lipofibroblast differentiation in the developing lung. , 2012, American journal of respiratory cell and molecular biology.

[34]  M. Redondo-Horcajo,et al.  Fatty acids revert the inhibition of respiration caused by the antidiabetic drug metformin to facilitate their mitochondrial β-oxidation. , 2012, Biochimica et biophysica acta.

[35]  N. Todd,et al.  Molecular and cellular mechanisms of pulmonary fibrosis , 2012, Fibrogenesis & tissue repair.

[36]  J. Torday,et al.  PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung , 2012, PPAR research.

[37]  C. Ruppert,et al.  Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis , 2012, European Respiratory Review.

[38]  B. Viollet,et al.  Cellular and molecular mechanisms of metformin: an overview. , 2012, Clinical science.

[39]  Philip Griebel,et al.  Peptide arrays for kinome analysis: New opportunities and remaining challenges , 2011, Proteomics.

[40]  Michael J. Cronce,et al.  Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition , 2011, Proceedings of the National Academy of Sciences.

[41]  M. Roden,et al.  The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact. , 2011, Trends in pharmacological sciences.

[42]  S. Mandrup,et al.  PPARγ in adipocyte differentiation and metabolism – Novel insights from genome‐wide studies , 2010, FEBS letters.

[43]  Henk M. W. Verheul,et al.  Strategies for kinome profiling in cancer and potential clinical applications: chemical proteomics and array-based methods , 2010, Analytical and bioanalytical chemistry.

[44]  M. Selman,et al.  Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study. , 2010, Respiratory medicine.

[45]  Allan R. Jones,et al.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain , 2009, Nature Neuroscience.

[46]  S. Belinsky,et al.  Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model. , 2007, Carcinogenesis.

[47]  B. Barna,et al.  Deletion of PPARγ in Alveolar Macrophages Is Associated with a Th-1 Pulmonary Inflammatory Response1 , 2009, The Journal of Immunology.

[48]  P. Chambon,et al.  Efficient temporally‐controlled targeted mutagenesis in smooth muscle cells of the adult mouse , 2009, Genesis.

[49]  N. Crowther,et al.  Metformin inhibits intracellular lipid accumulation in the murine pre‐adipocyte cell line, 3T3‐L1 , 2008, Diabetes, obesity & metabolism.

[50]  G. Hansmann,et al.  An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. , 2008, The Journal of clinical investigation.

[51]  Masato Kasuga,et al.  Dok1 mediates high-fat diet–induced adipocyte hypertrophy and obesity through modulation of PPAR-γ phosphorylation , 2008, Nature Medicine.

[52]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[53]  K. Kristiansen,et al.  Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis. , 2006, Molecular endocrinology.

[54]  J. Hoeijmakers,et al.  Dysregulation of the Peroxisome Proliferator-Activated Receptor Target Genes by XPD Mutations , 2005, Molecular and Cellular Biology.

[55]  T. Thatcher,et al.  PPARγ agonists inhibit TGF-β induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis , 2005 .

[56]  E. Mazzon,et al.  Effect of rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2 on bleomycin-induced lung injury , 2005, European Respiratory Journal.

[57]  T. Thatcher,et al.  PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[58]  G. Zhou,et al.  Insulin- and Mitogen-activated Protein Kinase-mediated Phosphorylation and Activation of Peroxisome Proliferator-activated Receptor γ* , 1996, The Journal of Biological Chemistry.